Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 19-Aug-24 8:25 AM View:  | Pacira Pharmaceuticals, Inc. (PCRX) | 16-Aug-24 | Private Purchase | 1,000 | $12.81 | $12,810.00 | 6% 16.55K to 17.55K | |
| 13-Jun-24 6:12 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 12-Jun-24 | Grant | 5,230 | -- | -- | 46% 11.32K to 16.55K | |
| 31-May-24 6:00 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 29-May-24 | Option Exercise | 6,652 | -- | -- | 49% 13.5K to 20.15K | |
| 14-Jun-23 5:14 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 12-Jun-23 | Private Sale (Planned) | 4,500 | $24.87 | $111,906.00 | (25%) 18.0K to 13.5K | |
| 07-Jun-23 9:18 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 05-Jun-23 | Sale (Planned) | 600 | $38.74 | $23,244.00 | (6%) 10.15K to 9.55K | |
| 05-Jun-23 9:42 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 01-Jun-23 | Option Exercise | 8,552 | -- | -- | 90% 9.45K to 18.0K | |
| 05-Apr-23 4:34 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 03-Apr-23 | Option Exercise | 7,000 | $29.90 | $209,300.00 | 69% 10.15K to 17.15K | |
| 05-Apr-23 4:34 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 03-Apr-23 | Planned Option Sale | 7,000 | $40.72 | $285,040.00 | (41%) 17.15K to 10.15K | |
| 17-Jan-23 5:17 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 12-Jan-23 | Option Exercise | 12,500 | $17.01 | $212,625.00 | 100% 0 to 12.5K | |
| 17-Jan-23 5:17 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 12-Jan-23 | Planned Option Sale | 12,500 | $18.25 | $228,125.00 | (100%) 12.5K to 0 | |
| 08-Jun-22 7:18 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 08-Jun-22 | Grant | 1,160 | -- | -- | 13% 8.99K to 10.15K | |
| 05-Jun-23 9:42 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 07-Jun-22 | Option Exercise | 6,391 | -- | -- | 209% 3.06K to 9.45K | |
| 05-Jun-23 9:42 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 22-Jun-21 | Option Exercise | 3,059 | -- | -- | 100% 0 to 3.06K | |
| 11-Jun-21 8:30 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 09-Jun-21 | Grant | 1,066 | -- | -- | 13% 7.92K to 8.99K | |
| 17-Nov-20 5:39 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 16-Nov-20 | Option Exercise | 12,000 | $13.98 | $167,760.00 | 151% 7.92K to 19.92K | |
| 17-Nov-20 5:39 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 16-Nov-20 | Market Option Sale | 12,000 | $65.95 | $791,400.00 | (60%) 19.92K to 7.92K | 10% |
| 02-Jul-20 4:24 PM View: | Portola Pharmaceuticals Inc (PTLA) | 02-Jul-20 | Disposition | 20,475 | $18.00 | $368,550.00 | (100%) 20.48K to 0 | |
| 15-Jun-20 6:49 PM View: | Portola Pharmaceuticals Inc (PTLA) | 12-Jun-20 | Grant | 7,281 | -- | -- | 55% 13.19K to 20.48K | |
| 11-Jun-20 6:21 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 09-Jun-20 | Grant | 1,260 | -- | -- | 19% 6.66K to 7.92K | |
| 08-Jun-20 9:04 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 05-Jun-20 | Market Sale | 2,100 | $48.70 | $102,270.00 | (24%) 8.76K to 6.66K | (22%) |
| 08-Jan-20 6:01 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 07-Jan-20 | Option Exercise | 10,000 | $1.75 | $17,500.00 | 100% 0 to 10.0K | |
| 08-Jan-20 6:01 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 07-Jan-20 | Market Option Sale (Planned) | 10,000 | $42.19 | $421,900.00 | (100%) 10.0K to 0 | |
| 12-Sep-19 4:21 PM View: | Mirum Pharmaceuticals, Inc. (MIRM) | 10-Sep-19 | Purchase | 10,000 | $11.22 | $112,200.00 | 100% 0 to 10.0K | |
| 17-Jun-19 5:14 PM View: | Portola Pharmaceuticals Inc (PTLA) | 13-Jun-19 | Grant | 4,194 | -- | -- | 47% 9.0K to 13.19K | |
| 06-Jun-19 4:27 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 05-Jun-19 | Grant | 4,134 | -- | -- | 89% 4.63K to 8.76K | |
| 11-Jan-19 4:32 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 09-Jan-19 | Option Exercise | 10,000 | $2.16 | $21,600.00 | 100% 0 to 10.0K | |
| 11-Jan-19 4:32 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 09-Jan-19 | Market Option Sale (Planned) | 10,000 | $20.00 | $200,041.00 | (100%) 10.0K to 0 | |
| 30-Jul-18 5:38 PM View: | Aratana Therapeutics, Inc. (PETX) | 27-Jul-18 | Grant | 4,500 | -- | -- | 50% 9.0K to 13.5K | |
| 15-Jun-18 7:12 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 13-Jun-18 | Grant | 782 | -- | -- | 20% 3.85K to 4.63K | |
| 08-Jun-18 5:56 PM View: | Portola Pharmaceuticals Inc (PTLA) | 08-Jun-18 | Grant | 3,000 | -- | -- | 50% 6.0K to 9.0K | |
| 04-Jan-18 6:23 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 02-Jan-18 | Option Exercise | 25,000 | $8.23 | $205,800.00 | 100% 0 to 25.0K | |
| 04-Jan-18 6:23 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 02-Jan-18 | Market Option Sale (Planned) | 25,000 | $30.06 | $751,542.00 | (100%) 25.0K to 0 | 52% |
| 23-Jun-17 5:28 PM View: | Aratana Therapeutics, Inc. (PETX) | 21-Jun-17 | Grant | 4,500 | -- | -- | 100% 4.5K to 9.0K | |
| 19-Jun-17 5:52 PM View: | Portola Pharmaceuticals Inc (PTLA) | 16-Jun-17 | Grant | 3,000 | -- | -- | 100% 0 to 3.0K | |
| 16-Jun-17 8:11 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 14-Jun-17 | Grant | 1,357 | -- | -- | 55% 2.49K to 3.85K | |
| 28-Jun-16 6:01 PM View: | Aratana Therapeutics, Inc. (PETX) | 24-Jun-16 | Grant | 4,500 | -- | -- | 100% 0 to 4.5K | |
| 20-Jun-16 3:41 PM View: | Portola Pharmaceuticals Inc (PTLA) | 17-Jun-16 | Grant | 3,000 | -- | -- | 100% 0 to 3.0K | |
| 17-Jun-16 4:49 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 15-Jun-16 | Grant | 1,488 | -- | -- | 149% 1.0K to 2.49K | |
| 08-Jun-16 7:04 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 06-Jun-16 | Market Sale (Planned) | 1,000 | $46.95 | $46,950.00 | (50%) 2.0K to 1.0K | (26%) |
| 05-Jun-15 6:28 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 03-Jun-15 | Grant | 2,000 | -- | -- | 100% 0 to 2.0K | |
| 13-Feb-15 5:57 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 11-Feb-15 | Option Exercise | 10,000 | $1.75 | $17,500.00 | 100% 0 to 10.0K | |
| 13-Feb-15 5:57 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 11-Feb-15 | Market Option Sale (Planned) | 10,000 | $33.63 | $336,349.00 | (100%) 10.0K to 0 | 57% |
| 16-Sep-14 6:05 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 15-Sep-14 | Option Exercise | 10,000 | $1.75 | $17,500.00 | 100% 0 to 10.0K | |
| 16-Sep-14 6:05 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 15-Sep-14 | Market Option Sale (Planned) | 10,000 | $28.07 | $280,669.00 | (100%) 10.0K to 0 | 49% |
| 09-Jul-14 6:37 PM View: | Delcath Systems Inc. (DCTH) | 07-Jul-14 | Grant | 9,616 | -- | -- | 466% 2.06K to 11.68K | |
| 09-May-14 8:29 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 09-May-14 | Option Exercise | 10,000 | $11.76 | $117,610.00 | 100% 0 to 10.0K | |
| 09-May-14 8:29 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 09-May-14 | Market Option Sale (Planned) | 10,000 | $73.85 | $738,450.00 | (100%) 10.0K to 0 | 20% |
| 04-Apr-14 7:52 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 04-Apr-14 | Option Exercise | 14,285 | $1.75 | $24,998.80 | 100% 0 to 14.29K | |
| 04-Apr-14 7:52 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 04-Apr-14 | Market Option Sale (Planned) | 14,285 | $22.54 | $321,925.00 | (100%) 14.29K to 0 | 36% |
| 17-Jan-14 5:43 PM View: | Acadia Pharmaceuticals Inc. (ACAD) | 15-Jan-14 | Option Exercise | 10,000 | $1.36 | $13,600.00 | 100% 0 to 10.0K |